Clinical Trial Update: Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electronic Patient-reported Outcome Application in Patients With IDH-mutated Glioma [NA]

View source ↗

Summary

This is a clinical trial update describing monitoring of neurological symptoms, treatment tolerance, and quality of life in IDH-mutated glioma patients using th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Oncology, Glioma | NA | Status: NOT_YET_RECRUITING